244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells

The epidermal growth factor receptor (EGFR) is known to play a critical role in non-small cell lung cancer(NSCLC). Several EGFR tyrosine kinase inhibitors(TKIs), such as gefitinib, have been used as effective clinical therapies for patients with NSCLC. Unfortunately, acquired resistance to gefitinib...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncotarget
Huvudupphovsmän: Zhang, Yi, Yao, Ke, Shi, Chengcheng, Jiang, Yanan, Liu, Kangdong, Zhao, Song, Chen, Hanyong, Reddy, Kanamata, Zhang, Chengjuan, Chang, Xiaoyu, Ryu, Joohyun, Bode, Ann M., Dong, Ziming, Dong, Zigang
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals LLC 2015
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4792556/
https://ncbi.nlm.nih.gov/pubmed/26517520
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk